Results of ruthenium irradiation of uveal melanoma
| Autor: | J. A. Oosterhuis, J. Davelaar, Jan Willem H. Leer, H. de Vroome, Reina E. Tjho-Heslinga, H.M. Kakebeeke-Kemme, J.C. Bleeker |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Adult
Male Uveal Neoplasms medicine.medical_specialty medicine.medical_treatment Brachytherapy chemistry.chemical_element Stable Disease Complete regression medicine Humans Radiology Nuclear Medicine and imaging Irradiation Melanoma Aged Aged 80 and over Radiological and Ultrasound Technology business.industry Hematology Middle Aged medicine.disease eye diseases Ruthenium Surgery Radiation therapy chemistry Oncology Eye melanoma Cancer research Female Ruthenium Radioisotopes Nuclear medicine business Follow-Up Studies |
| Zdroj: | Radiotherapy and Oncology. 29:33-38 |
| ISSN: | 0167-8140 |
| DOI: | 10.1016/0167-8140(93)90170-d |
| Popis: | The follow-up results are presented for the radiotherapeutic treatment of 49 patients with uveal eye melanoma using ruthenium-106 ( 106 Ru 106 Rh ) applicators. Graded doses were applied and the degree of regression was found to be correlated with the dose at the top of the tumour. Complete regression is found in 66% of the patients treated with a top dose above 150 Gy, in which case the initial tumour prominence diminishes in about three years to a stable disease or to a flat scar. At this dose a marginal increase in complications was observed as compared with lower dose groups. Useful vision could be preserved in 75% of the eyes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|